Abstract
Introduction:
Abdominal aortic aneurysm (AAA) is a chronic vascular disease marked by chronic inflammation and immune dysregulation. The C-C motif chemokine ligand 20 (CCL20) - C-C motif chemokine receptor type 6 (CCR6) axis modulates immune responses in vascular diseases, but its role in AAA remains unclear. This study investigates the involvement of the CCL20-CCR6 axis in AAA formation.
Methods:
Single-cell RNA sequencing datasets and bulk RNA sequencing datasets were analyzed to assess cellular composition and transcriptional changes. Transcriptomic analysis, enzyme-linked immunosorbent assay, UK Biobank database analysis, CellChat analysis, immunofluorescence staining, and mouse models were employed to explore the CCL20-CCR6 axis in AAA.
Results:
Substantial immune cell infiltration (T lymphocytes & B lymphocytes) and loss of structural cells (fibroblasts, endothelial cells and smooth muscle cells) were identified using single-cell RNA sequencing datasets. Macrophage polarization was imbalanced, with enriched M1-like macrophages and elevated CCL20 secretion. Macrophages could promote the formation of AAA by recruiting a large number of immune cells via the CCL20-CCR6 axis. In vitro, CCL20 neutralization reduced immune cell recruitment; in vivo, the knockdown of this axis inhibited AAA progression.
Conclusions:
Macrophage-derived CCL20 aggravates lymphocyte recruitment via the CCR6, promoting AAA progression. CCL20 may serve as a biomarker for AAA. Targeting the CCL20-CCR6 axis could inhibit immune recruitment and AAA progression.
1 Introduction
Abdominal aortic aneurysm (AAA) represents a progressive, life-threatening vascular condition characterized by irreversible dilation of the abdominal aorta, often culminating in rupture. Epidemiological data indicate an incidence of 2-8% among individuals over 65 years, with rupture-associated mortality reaching 24.5% despite advancements in endovascular repair (1–3). Current clinical strategies rely predominantly on surgical interventions, as effective pharmacological therapies remain elusive, underscoring the urgent need for novel therapeutic targets to mitigate AAA progression and improve patient outcomes.
The pathogenesis of AAA is intricately linked to chronic inflammation, immune dysregulation, and structural degradation of the aortic wall. Key hallmarks include macrophage polarization, apoptosis of vascular smooth muscle cells (SMCs), and extracellular matrix remodeling (4–6). Emerging evidence highlights the pivotal role of immune cells in driving this inflammatory cascade, with macrophages acting as key regulators (7–9). Specifically, a variety of immune cells contribute to AAA progression in both human tissues and Angiotensin II (Ang II)-induced Apolipoprotein E-/- (ApoE-/-) mice models (10–12), including macrophages (13–15), T lymphocytes (T cells) (13, 14), and B lymphocytes (B cells) (16, 17). Macrophage-mediated immune regulation is pivotal in AAA progression (8, 18), where M1 macrophage polarization and associated inflammation drive aneurysm formation via proteolytic enzymes and pro-inflammatory cytokines (18–20). This polarization imbalance, triggered by environmental cues, sustains chronic inflammation and disrupts M1/M2 equilibrium (21, 22).
Within AAA tissues, macrophages interact closely with T and B cells (17, 23), facilitating immune cell communication and recruitment. Macrophages enhance T-cell infiltration through cytokine and chemokine signaling (24), while T cells, as predominant infiltrates in AAA (25), amplify progression via cytokine secretion (26–28). B cells contribute to AAA progression through immunoglobulin production and cytokines (16, 29), and their depletion in mice attenuates aneurysms by fostering immunosuppression (30, 31). However, the full mechanisms of immune cell infiltration and interactions in AAA remain unclear (32), necessitating further investigation for deeper insights.
C-C chemokine ligand 20 (CCL20), also known as macrophage inflammatory protein-3α, is produced by multiple cell types in the vascular wall, including activated endothelial cells, SMCs, stromal cells, and infiltrating monocytes/macrophages, particularly under inflammatory conditions (33–35). Through its interaction with its exclusive receptor, C-C motif chemokine receptor type 6 (CCR6), which is expressed on T cells, B cells, Natural Killer T (NKT) cells, and neutrophils (33, 36, 37), CCL20 mediates the recruitment of these immune cells to inflammatory sites (38, 39). The CCL20-CCR6 axis has garnered significant interest in recent years, as evidenced by studies establishing its functional involvement in vascular pathologies (37, 40, 41). However, the relationship between the CCL20-CCR6 axis and the pathogenesis of AAA has yet to be fully understood.
This study integrates single-cell RNA sequencing datasets and bulk RNA sequencing datasets with experimental validations to reveal how macrophage polarization imbalances promote immune recruitment and inflammation via the CCL20-CCR6 axis. Overall, these findings offer novel perspectives on immune regulation in AAA, positioning the CCL20-CCR6 axis as a critical contributor to AAA progression. The intervention experiments are employed to investigate the role and mechanism of this axis in AAA progression, with the aim to provide valuable insights into the immune regulatory mechanisms and therapeutic potential of the CCL20-CCR6 axis in AAA pathogenesis and progression.
2 Materials and methods
2.1 Collection of human abdominal aortic tissue and peripheral blood samples
This study was conducted in accordance with the principles of the Declaration of Helsinki and received approval from the Ethics Committee of Qilu Hospital of Shandong University (Approval No.: KYLL-202503-09-046-1) for human samples. Written informed consent was obtained from all participants or the families of organ donors. Human abdominal aortic aneurysm (AAA) tissues were collected from six patients (4 males, 2 females; age range: 58–71 years, mean: 65.83 years, median: 67.5 years, standard deviation(SD) = 5.27, interquartile range (IQR): 10) undergoing open surgical repair for AAA. Normal aortic tissues were obtained from five organ donors (5 males; age range: 51–74 years, mean: 58 years, median: 56 years, standard deviation(SD) = 9.92, interquartile range (IQR): 17) who had died from cerebral hemorrhage. The demographics and comorbidities of the AAA patients and organ donors are summarized in Supplementary Table 1. These tissues were used for Western blot, immunohistochemistry (IHC), immunofluorescence (IF) staining and multiplex immunofluorescence (mIF).
Serum samples were collected from 80 patients with AAA and 79 healthy controls. Inclusion criteria for AAA patients included an AAA diameter exceeding 30 mm and a definite diagnosis of AAA confirmed by computed tomography angiography of the full aorta. Exclusion criteria for AAA patients encompassed false (infected, inflammatory, or traumatic) or dissected AAAs, those caused by genetic or connective tissue diseases such as Ehlers-Danlos syndrome or Marfan syndrome, a previous history of open or endovascular repair for AAAs, malignant tumors, acute or chronic infections, autoimmune diseases, and current use of antibiotics, anti-inflammatory drugs, or immunosuppressive therapy. The control group consisted of healthy individuals matched for age and gender. Serum samples from AAA patients were obtained from the Department of Vascular Surgery at Qilu Hospital of Shandong University, while those from controls were collected from the Department of Health Management Center at the same institution. Demographic and clinical information for both groups is summarized in Supplementary Table 2. All samples were stored at 4°C until analysis.
2.2 Animal experiments
All animal procedures followed the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Experimental Animal Ethics Committee of Qilu Hospital of Shandong University (Approval No.: DWLL-2024-214). Eight-week-old ApoE-/- male mice (C57BL/6J background) were obtained from Vital River Laboratory (China) and housed in pathogen-free conditions (12-h light/dark cycle, 24 ± 2°C, 40 ± 5% humidity, five mice per cage). The mice were fed with a Western diet for four weeks to induce the formation of AAA. The western-style diet (high cholesterol diet) consisted of 17.3% protein, 21.2% fat, 48.5% carbohydrates, 0.2% cholesterol by mass, contributing 42% of total calories from fat (TD.88137, Envigo).
2.3 Angiotensin II-induced mice AAA model
To induce AAA, osmotic pumps (RWD Life Science, model 2004w, China) delivering Ang II (1000 ng/kg/min, Sigma-Aldrich, USA) were subcutaneously implanted in 8-week-old ApoE-/- male mice (42). A total of 75 mice were randomly assigned to 5 experimental groups (n=15 per group): 1) Negative Control group; 2) AAV-shRNA (empty vector) group; 3) AAA model group; 4) AAV-shCCL20-treated AAA model group; and 5) AAV-CCR6-treated AAA model group. Mice were monitored daily for activity and mortality; aortic diameter was assessed weekly via Doppler ultrasound (FUJIFILM Visual Sonics, Japan). After 4 weeks, mice were euthanized with Carbon Dioxide (CO2), and tissues were harvested.
2.4 AAV-mediated CCL20/CCR6 intervention In Vivo
To investigate the role of CCL20/CCR6 in AAA development, ApoE-/- mice received tail vein injections of Adeno-Associated Viruses (AAV) carrying AAV9-cmv-shCCL20, AAV9-cmv-shCCR6, or a negative control (2×10-11vector genomes). ShRNA sequences and serotype AAV9 viruses carrying these sequences or a negative control were purchased from Cyagen (China). The target shCCL20 sequence was: 5’-CCAAAGCAGAACTGGGTGAAA-3’; the target shCCR6 sequence was: 5’-GATCCATGACTGACGTCTACCT-3’.
2.5 Blood pressure measurement
Mouse systolic blood pressure, diastolic blood pressure, and heart rate were measured using a non-invasive tail-cuff system (BP-98A, Softron, Japan) pre- and post-model induction and during the modeling period.
2.6 Ultrasound examination
AAA was defined as a ≥ 50% dilation of the abdominal aortic diameter compared to the normal diameter in mice. Vascular Doppler ultrasound provided a rapid, effective, and non-invasive method for monitoring abdominal aortic diameter. Mice were anesthetized with 2% isoflurane, and hair was removed from the chest to abdomen using depilatory cream. Ultrasound coupling gel was applied to the abdomen of each mouse. Using an Doppler ultrasound system (Visual Sonics Vevo 2100, FUJIFILM, Japan) equipped with a 40 MHz transducer, the probe position was adjusted to identify the abdominal aorta via B-mode ultrasound. Color and spectral Doppler were used to confirm the blood direction and velocity consistent with aortic signals. The abdominal aortic diameter was measured three times per mouse via B-mode, color, and spectral Doppler.
2.7 Histopathological analysis
Mouse aortas were fixed in 4% paraformaldehyde for 24 hours, dehydrated through a graded ethanol series, cleared in xylene, embedded in paraffin, and sectioned into 5 μm serial slices. After standard deparaffinization and rehydration, the sections were processed as follows: Oil Red O staining for lipid deposition, hematoxylin and eosin staining (Sigma-Aldrich, USA) for histopathological changes and vascular integrity, elastic Van Gieson staining (Sigma-Aldrich, USA) for elastic fiber fragmentation, and Masson’s trichrome staining (Solarbio, China) for collagen deposition. Stained sections were observed under a microscope (Nikon Eclipse E100, Japan) and analyzed quantitatively using ImageJ software (three fields per sample, double-blinded). Elastic degradation was graded as follows: Grade 1, intact with no degradation; Grade 2, mild elastic degradation; Grade 3, severe elastic degradation; Grade 4, aortic rupture.
2.8 Immunohistochemistry
IHC was performed using an IHC kit (Solarbio, China). Sections were deparaffinized, subjected to heat-induced ethylenediaminetetraacetic acid (EDTA) epitope retrieval, blocked with goat serum, and incubated overnight at 4°C with primary antibodies: CD3 (Abcam, ab16669, 1:200, UK), CD19 (Abcam, ab245235, 1:200, UK), and CD68 (Abcam, ab282654, 1:150, UK). After washing with phosphate-buffered saline three times (5 minutes each), sections were incubated with biotinylated secondary antibodies, stained with 3,3’ -diaminobenzidine, and counterstained with hematoxylin. Stained sections were imaged under a microscope (Nikon Eclipse E100, Japan), and CD3+/CD19+/CD68+ cells were quantified by two independent pathologists blinded to the groups. Ten random high-power fields (50 × magnification) per section were selected for positive cell counting.
2.9 Immunofluorescence staining and multiplex immunofluorescence
Human and mouse aortic tissues were fixed in 10% neutral buffered formalin, paraffin-embedded, and sectioned. Sections were deparaffinized in xylene and graded ethanol, subjected to heat-induced EDTA epitope retrieval, and blocked with goat serum for 1 hour. Sections. They were incubated overnight at 4°C with primary antibodies: CD3 (Abcam, ab16669, 1:200, UK), CD19 (Abcam, ab245235, 1:200, UK), CCL20 (Proteintech, 26527-1-AP, 1:200, China), CD68 (Abcam, ab282654, 1:150, UK), CCR6 (Abcam, ab303672, 1:150, UK), CD204 (Abcam, ab314227, 1:150, UK), and CD86 (Cell Signaling Technology, 91882T, 1:100, USA). After washing, sections were incubated with secondary antibodies at room temperature for 1 hour: Alexa Fluor 488 anti-rabbit (Proteintech, RGAR002, 1:200, China), Alexa Fluor 594 anti-rabbit (Proteintech, RGAR002, 1:200, China), and Alexa Fluor 555 anti-rabbit (Proteintech, RGAR003, 1:200, China).
Multiplex immunofluorescence was performed on formalin-fixed, paraffin-embedded (FFPE) tissue sections using the Tyramide Signal Amplification (TSA) technique. Each round consisted of the following cycle: incubation with a primary antibody, followed by an HRP-conjugated secondary antibody, and then the corresponding TSA fluorescent dye (Opal series): CD68 (Genetech, GM087629, 1:200, China, PPD 520), CD86 (Cell Signaling Technology, 19589S, 1:100, USA, PPD 570), CD206 (Cell Signaling Technology, 24595, 1:100, USA, PPD 570), CD163 (Abcam, Ab182422, 1:150, UK, PPD 620), iNOS (Bioss Antibodies, BS-0162R,1:200, China, PPD 620), Arg1 (Abclonal biotechnology, A25808, 1:200, USA, PPD 620), F4/80 (Cell Signaling Technology, 70076S, 1:100, USA, PPD 520). Nuclei were counterstained with DAPI, and stained sections were examined under a confocal fluorescence microscope (Zeiss LSM 780, Germany).
2.10 Enzyme-linked immunosorbent assay
Serum CCL20 levels in AAA patients and healthy controls were quantified using a commercial ELISA kit (Proteintech, KE00149, China), following the manufacturer’s protocol. Absorbance was measured at 450 nm.
2.11 Real-time quantitative PCR
Total RNA was extracted from tissues using a Tissue DNA Extraction Kit (TIANGEN, China). cDNA was synthesized, mixed with SYBR® Green (Accurate Biology, AG11701, China) and primers, and amplified per the manufacturer’s instructions. Relative gene expression was calculated using the 2^−ΔΔCt method with GAPDH as the reference gene. Primer sequences are shown in Supplementary Table 3.
2.12 Western blot analysis
Aortic tissue proteins were extracted using radioimmunoprecipitation assay lysis buffer, separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and transferred to polyvinylidene fluoride membranes. Membranes were blocked with 5% skim milk, incubated overnight at 4°C with primary antibodies (CCR6, abcam, ab227036 & GAPDH, Proteintech, 60004-1-Ig), washed with Tris-Buffered Saline with Tween 20 buffer, incubated with secondary antibodies, and detected using an enhanced chemiluminescence reagent on a chemiluminescence imaging system (Azure Biosystems, USA). Quantification was performed using the ImageJ software for digital image analysis.
2.13 Transwell assay
A Transwell assay was performed to evaluate the chemotactic ability of macrophages toward B and T cells under inflammatory conditions. Mouse bone marrow-derived macrophages were stimulated with lipopolysaccharide (LPS) (100 ng/mL, L2880, Sigma-Aldrich, USA) for 24 hours, and the cell supernatant was collected. Using Transwell chambers (0.4 μm pore size, LabSelect, 14112), 2×105 B or T cells were seeded in the upper chamber with serum-free medium, and supernatant was added to the lower chamber. After 48 hours, migrated cells were analyzed by flow cytometry.
2.14 Single-cell data analysis
Single-cell data used in this study were searched and downloaded from the Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/) under the accession numbers GSE166676 and GSE226492. The UMI expression matrix (10 × files) with genes expressed in at least 5 cells and cells expressing at least 200 genes was loaded into Seurat (version 5.3.0) (43). Further cleaning steps were performed using nCount within twofold standard deviation, nFeature within twofold standard deviation, and mitochondria percentage below 15%. Mitochondrial genes, ribosomal genes, and the MALAT1 gene were then removed from the expression dataset to minimize technical noise during downstream normalization and dimensionality reduction. The SCTransform function was used for data normalization, scaling, and transformation, with S.Score and G2M.Score (calculated using the CellCycleScoring function based on S- and G2/M-phase-specific genes) included as covariates to regress out cell cycle-associated variation. DoubletFinder (version 2.0.6) was then used for the identification and removal of double cells (44). The R package scCDC (version 1.4) was used for the gene-specific contamination detection and correction in single-cell RNA-seq data (45).
After data merging, dimensionality reduction was performed using the RunPCA function, and the number of retained principal components was determined using a quantitative elbow-based approach. PCs were retained when individual variance explained fell below 5% while cumulative variance exceeded 90%, and when the change in variance explained between consecutive PCs was <0.1%. The final PC number (14) was conservatively selected as the minimum value satisfying these criteria. To correct for batch effects between the two independent GEO datasets, Harmony integration (R package harmony, version 1.2.4) was then applied to the PCA embeddings using dataset identity as the batch variable. The Harmony-corrected low-dimensional representations were subsequently used for FindNeighbors and UMAP analyses.
The cell clusters were identified using the FindClusters function with a resolution of 0.7 and the Leiden algorithm. Marker genes for each cluster were identified using the FindAllMarkers function with the Wilcoxon rank-sum test under the following criteria: avg_log2FC > 0.25, p_val_adj < 0.05, pct1 > 0.1, and pct2 < 0.5. This analysis was performed for cluster marker identification and cell-type annotation purposes, rather than for donor-level differential expression inference. The AddModuleScore function was used to calculate module scores for predefined feature expression programs (e.g., M1-like or M2-like macrophage signatures) at the single-cell level.
2.15 Ro/e analysis
To assess the distributional preference of each cell cluster across different tissues or samples, we calculated the observed-to-expected ratio (Ro/e = Observed/Expected) using the R package Startrac (version 0.1.0) (46). In this analysis, cells were pooled within each condition, and the expected distribution was defined under the assumption of independence between cell cluster identity and tissue category, estimated from the marginal distributions of all pooled cells. Statistical significance was evaluated using Fisher’s exact tests as implemented in Startrac, with Benjamini–Hochberg correction applied for multiple testing. Cell clusters with adjusted P values < 0.05 were considered to show significant deviation from the expected distribution.
A Ro/e value greater than 1 indicates that a given cell cluster is overrepresented in a particular tissue relative to the expected distribution, whereas a Ro/e value less than 1 denotes relative underrepresentation. We note that this Ro/e analysis was performed at the cell level and does not explicitly account for donor-level structure. Due to the limited number of donors and sparse representation of certain cell clusters across individual samples, donor-aware Ro/e analysis was not statistically feasible. Therefore, Ro/e results are presented as a descriptive summary of cell-type distribution patterns rather than as formal donor-level inference and should be interpreted with appropriate caution.
2.16 Cell-cell communication analysis using CellChat
Cell-cell communication analysis was performed using the R package CellChat (version 2.2.0) (47), which infers putative intercellular communication networks based on the expression of known ligand-receptor pairs. Normalized single-cell expression data and annotated cell types were used to estimate communication probabilities between cell populations. CellChat analysis was conducted on pooled single-cell datasets within each condition to characterize global communication patterns. Inferred interaction strength and pathway-level signaling patterns were quantified and visualized using the built-in CellChat functions, with the understanding that these measures reflect relative communication tendencies and may be influenced by cell-type abundance. Comparative analysis of signaling pathways between AAA and normal groups was performed to identify pathways showing condition-associated differences. The CCL signaling pathway was selected for focused analysis based on differential gene expression and pathway enrichment results, given its established relevance to inflammatory processes in AAA.
2.17 Bulk RNA-seq data analysis
The expression matrix data of two AAA-related bulk RNA-seq datasets (GSE183464 and GSE269845) were downloaded from the GEO database and processed independently using identical analysis pipelines. All analyses were performed in R (version 4.5.1). For each dataset, gene re-annotation and removal of low-expression genes were conducted prior to downstream analyses. Exploratory PCA was performed separately for each dataset for quality assessment. Differential expression analysis was then performed separately within each dataset using the limma-trend pipeline implemented in the limma (version 3.65.4) and edgeR (version 4.7.3) packages with disease status as the primary comparison (48, 49). Differentially expressed genes were visualized using volcano plots. Genes that were consistently upregulated or downregulated in both datasets were considered AAA-associated differentially expressed genes. Functional enrichment analyses, including GO and KEGG enrichment based on the overlapping DEGs, as well as GSEA based on the logFC values of all genes, were performed using the clusterProfiler package (version 4.17.0) (50).
2.18 Immune cell deconvolution using CIBERSORTx
Immune cell composition in bulk RNA-seq samples was estimated using the CIBERSORTx method (51), a computational framework for digital cytometry based on gene expression signatures. Normalized gene expression matrices were uploaded to the CIBERSORTx web portal (https://cibersortx.stanford.edu/index.php), and the LM22 signature matrix was used to quantify the relative fractions of 22 immune cell types. Statistical significance of each cell-type proportion was assessed using 1000 permutations, and samples with P < 0.05 were considered reliable for downstream analysis. Fractional abundances were further analyzed and visualized using R to compare immune cell composition across groups or conditions.
2.19 ScRNA-seq phenotype association using SCISSOR
Phenotype-associated single-cell populations were identified using the SCISSOR algorithm by the R package Scissor (version 2.0.0) (52), which integrates single-cell RNA-seq data with bulk phenotypic information (AAA and normal group). Each cell was assigned a score reflecting its association with the phenotype, and cells with significant positive or negative associations were selected for downstream analyses. Associated subpopulations were visualized using UMAP and heatmaps to highlight their distribution within the single-cell landscape.
2.20 Flow cytometry
Cells were centrifuged at 300 × g for 5 minutes at 4°C. The resulting cell pellet was resuspended in a buffer containing 0.5% bovine serum albumin. Cell viability and count were determined using trypan blue exclusion and an automated cell counter (Countess, Life Technologies, USA). Anti-CD16/CD32 antibody (BioLegend, 101302, USA) was added and incubated at room temperature for 10 minutes to minimize non-specific binding. Subsequently, cells were stained with fluorochrome-conjugated antibodies: FITC anti-mouse CD3 (BioLegend, 100203, USA), PE anti-mouse F4/80 (eBioscience, 12-4801-82, USA), and FITC anti-mouse CD19 (BioLegend, 115507, USA). Data were analyzed using FlowJo software.
2.21 Analysis of the UK biobank database
The UK Biobank received ethical approval from the North West Multi-Centre Research Ethics Committee (REC reference: 16/NW/0274). All participants provided informed consent to participate. The present analyses were conducted under UK Biobank application number 151350.
From a total of 502,128 participants in the UK Biobank, we excluded 450,068 individuals with missing data on the CCL20 protein level. After further excluding those with a baseline abdominal aortic aneurysm, the final analytical cohort comprised 52,017 individuals. This cohort was used to assess the association between circulating CCL20 levels at baseline and the risk of incident AAA. The baseline CCL20 levels were compared between participants who developed incident AAA and those who did not using a t-test. Multivariable Cox regression models were used to estimate hazard ratios (HR) and 95% confidence intervals (CI) for the association between circulating CCL20 level and risk of incident AAA. Multivariable-adjusted model was adjusted for age, sex, ethnicity, educational attainment, socioeconomic deprivation, body mass index, smoking status, alcohol drinking, healthy diet, leisure time physical activity, diabetes, hypertension, and hypercholesterolemia.
2.22 Statistical analysis
Statistical analyses were performed using GraphPad Prism 8.0 and R 4.5.1 in this study. In vitro and in vivo results are presented as mean ± standard error of the mean. Student’s t-test (normal data) or Wilcoxon test (non-normal data) was performed to compare the means between two groups. Multiple group comparisons were conducted by one-way or two-way analysis of variance (ANOVA). Correlation analysis was performed using the Spearman method by the R package ggstatsplot (version 0.13.1). Statistical graphs were visualized by GraphPad Prism 9.5 or the R package ggplot2 (version 3.5.2). P < 0.05 was considered significant. Details of the statistical analysis were mentioned in each Figure legend.
3 Results
3.1 Immune cell infiltration and structural cell depletion in AAA
To examine the transcriptional landscape of the human abdominal aorta and determine cellular alterations in AAA tissues, two single-cell RNA-seq datasets (GSE166676: 2 normal, 4 AAA samples; GSE226492: 3 normal, 3 AAA samples) were downloaded from the Gene Expression Omnibus (GEO) database. After quality control and batch effects correction, 67,656 cells were obtained (39,782 normal, 27,874 AAA; Supplementary Figures 1A–C). All of the cells were categorized into 16 clusters (Supplementary Figures 1D–F). Based on cellular marker genes, cells were clustered and further annotated into 11 distinct main types (Figures 1A, B).
Figure 1
To detect the variability in the proportions of different cell types across groups, we calculated the proportions of all cells from the two groups. Compared with the normal group, the proportion of structural cells was substantially decreased in AAA tissues, including fibroblasts (from 34.63% to 11.52%), endothelial cells (from 17.59% to 3.89%), and SMCs (from 12.95% to 1.66%) (Figures 1C–E, G). Conversely, immune cells such as T cells (from 3.84% to 22.35%), B cells (from 1.92% to 29.59%), and NKT cells (from 2.39% to 7.14%) were significantly enriched (Figures 1C–E, H), indicating substantial immune cell infiltration and immune microenvironment remodeling in AAA, while the proportion of macrophages showed minimal change (from 13.14% to 13.54%) (Figures 1C–E).
To further evaluate the tissue distribution preferences of different cell types, we performed Ro/e preference analysis. The results demonstrated that structural cells (fibroblasts, endothelial cells, and SMCs) were less prevalent in the AAA group compared to the normal group (Figure 1F), whereas immune cells (T cells, B cells, and NKT cells) exhibited preferential enrichment in AAA tissues (Figure 1F). IHC and IF staining of human aortic tissues further confirmed the enrichment of T cells and B cells (Figures 1I, J; Supplementary Figures 1G, H). Consistent with prior research (53), findings revealed a profound cellular imbalance in AAA tissues, characterized by extensive immune cell infiltration (T cells and B cells) and loss of structural cells (fibroblasts, endothelial cells, and SMCs).
3.2 Inflammatory and immune responses were activated in AAA
To investigate the transcriptomic signatures between AAA and normal tissues, two human bulk RNA-seq datasets (GSE183464 and GSE269845) were downloaded from the GEO database. Results of Principal component analysis (PCA) revealed significant transcriptomic heterogeneity between the groups (Figures 2A, B). We then identified differentially expressed genes (DEGs) using the threshold described in the Methods section, comparing the AAA and normal groups in both datasets. Upregulated genes (e.g., C-C motif chemokine receptor 7 (CCR7), C-X-C motif chemokine receptor 4 (CXCR4), Cluster of Differentiation 79A (CD79A) were associated with immune responses, immune cell activation, and cell communication, whereas downregulated genes (e.g., Actin Alpha Cardiac Muscle 1 (ACTC1), Collagen, type IV, alpha 3 chain (COL4A3), Actinin, alpha 2 (ACTN2) were linked to vascular structure and cytoskeleton organization (Figures 2C, D). A Venn diagram showed that 589 genes were consistently upregulated and 449 genes were consistently downregulated in the two datasets (Figure 2E).
Figure 2
Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment indicated upregulated genes were enriched in inflammatory processes, immune activation, and cytokine chemotaxis, while downregulated genes related to extracellular matrix degradation and smooth muscle contraction (Figures 2F, G; Supplementary Figure 2). Gene set enrichment analysis (GSEA) confirmed immune-related pathways (e.g., B/T cell receptor signaling, cytokine-cytokine receptor interaction, chemokine signaling, and lipid metabolism) were significantly active in AAA; whereas pathways related to aortic structure (e.g., extracellular matrix-receptor interaction, SMC cytoskeleton, and vascular smooth muscle contraction) were suppressed (Figures 2H, I). These results demonstrated that AAA tissues exhibited enhanced inflammatory and immune responses accompanied by the disruption of vascular wall integrity.
3.3 Macrophage polarization influenced the progression of AAA
To identify cell types associated with the progression of AAA and further explore their biological characteristics, the Scissor algorithm was performed using the datasets GSE183464 and GSE269845, respectively, and a higher proportion of Scissor+ cells was obtained in the AAA group (Supplementary Figures 3A, B). In terms of relative proportions, there are more Scissor+ cells in macrophages, and SMC exhibited the highest proportion of Scissor- cells (Figures 3A, B), indicating that macrophages play a critical role in AAA pathogenesis. However, single-cell data analysis (Figure 1E) and IHC staining (Figure 3C) revealed no significant change in the proportion of macrophages between the AAA and normal groups.
Figure 3
CIBERSORTx was performed to investigate the difference in the composition of immune cell subsets between the AAA and normal groups, and the relative proportions of immune cell infiltration were calculated (Supplementary Figures 3C, D). Compared with the normal group, the AAA group showed a significant decrease in NK cells activated, monocytes, and M2 macrophages in GSE183464 (Figure 3D). In GSE269845, the AAA group exhibited a significant decrease in macrophages M0, and macrophages M2 (Figure 3E). The results demonstrated that the proportion of M2 macrophages was statistically significantly reduced in the AAA group of two datasets.
The single-cell datasets revealed that the M1-like macrophage signature module score was upregulated in the AAA group, while the normal group exhibited a higher M2-like macrophage module score (Figure 3F). Furthermore, macrophages in the AAA group expressed elevated M1-like macrophage signatures, while the normal group exhibited higher expression of M2-like macrophage signatures (Figure 3G). Additionally, Cluster of Differentiation 204 (CD204) (MSR1) was highly expressed in healthy human aortas, and a higher expression level of Cluster of Differentiation 86 (CD86) was observed in the AAA tissues (Figure 3H; Supplementary Figures 3E, F). We further characterized macrophage polarization through multiplex immunofluorescence staining by identifying additional M1/M2 markers to provide a more comprehensive assessment of macrophage polarization. In human samples, macrophages with pro-inflammatory M1-like features were identified as CD68+CD86+iNOS+, and macrophages with anti-inflammatory M2-like features were identified as CD68+CD163+CD206+, reflecting their functional polarization tendencies (Supplementary Figures 3G, H). Our results show that macrophages in AAA samples exhibited a stronger M1-like functional profile, indicating M1 polarization, while in normal samples, macrophages displayed higher expression of M2 markers, including CD68+CD163+CD206+. These findings indicated that the proportion of macrophages showed little change, while the imbalance between M1-like and M2-like macrophage polarization might influence the AAA progression.
3.4 Macrophages exhibited altered gene expression accompanied by abundant secretion of CCL20 in AAA
Macrophages have been shown to play a critical pathophysiological role in AAA progression (8, 54). After identifying the imbalance of macrophage polarization between the normal and AAA groups, we investigated the gene expression in macrophages. DEG analysis was performed using the single-cell datasets on macrophages between the AAA and normal groups. Compared to the normal group, 139 upregulated and 105 downregulated DEGs were obtained in AAA macrophages (Figure 4A). GO term and KEGG pathway enrichment analysis demonstrated that the upregulated genes were significantly associated with biological processes, including chemotaxis, cell chemotaxis, immune and inflammatory response, and pathways including Tumor Necrosis Factor (TNF) signaling pathway, Peroxisome Proliferator-Activated Receptor (PPAR) signaling pathway, chemokine signaling pathway, cytokine-cytokine receptor interaction pathway, and so on (Figures 4B, C). GSEA further confirmed that these processes and pathways were activated in the AAA group (Figure 4D). RT-qPCR was performed to validate these findings in human AAA tissues. The results showed that expression of genes related to immune response and chemotaxis (Interleukin-1 β (IL-1β), Interleukin-8 (IL-8), and TNF-α) was elevated (Figure 4E). Additionally, the expression levels of lipid metabolism-related markers (Acetyl-CoA Carboxylase 1 (ACC1), Fatty Acid Synthase (FASN), and PPAR-γ) were elevated (Figure 4F). Oil Red O staining also revealed notable lipid deposition in the aneurysm (Figure 4G). These results demonstrated inflammatory and lipid accumulation features in macrophages of AAA.
Figure 4
Given the significant enrichment observed (Figures 4B, C), we investigated the cytokine-cytokine receptor interaction pathway and ranked the average log2FC values of the associated upregulated DEGs (Figure 4H, Supplementary Figure 4D). Among these, Interleukin-1 α (IL-1α), C-X-C motif chemokine ligand 10 (CXCL10), and CCL20 were the top three elevated factors in macrophages from AAA. single-cell datasets revealed that CCL20 was primarily and highly expressed in macrophages across all 11 cell types analyzed (Figure 4I). IF co-localization further confirmed that CCL20 is predominantly present in macrophages (Figure 4J). Compared to the normal group, CCL20 expression in macrophages was significantly elevated in AAA tissues (Figure 4K), which was also evident in the GSE183464 and GSE269845 datasets (Supplementary Figure 4A).
Considering the secretory nature of CCL20 and its previously validated diagnostic efficacy as a biomarker (55), serum samples were collected from 80 AAA patients and 79 healthy controls for ELISA analysis (Supplementary Table 2). The results indicated significantly higher CCL20 levels in AAA patients compared to healthy controls (Figure 4L), with an AUC value of 0.7 (Figure 4M).
To make an external validation, we analyzed the data from the UK Biobank. In the cohort of 52,017 participants, 329 incident AAA cases were identified during a median follow-up of 13.59 years. The demographic characteristics of participants were shown in Table 1. Multivariable Cox regression results showed that a per 1-SD increase in circulating CCL20 level was associated with increased risk of AAA. Compared to participants with the lowest quartiles (Q1) of CCL20, those with the highest quartiles (Q4) had a 44% increased risk of incident AAA (HR: 1.44; 95% CI: 1.02, 2.03; P = 0.040) (Table 2, Supplementary Figure 4C). Additionally, CCL20 expression was increased in human AAA tissues relative to normal abdominal aortic tissues (Figure 4N, Supplementary Figure 4B). These findings suggest that CCL20 is primarily secreted by macrophages in AAA, with elevated levels in both tissues and blood, potentially implicating it in AAA progression.
Table 1
| Characteristic | Total population | Participants without AAA | Participants with AAA | P-value |
|---|---|---|---|---|
| N | 52,017 | 51,688 | 329 | |
| Age, years | 56.79 ± 8.21 | 56.75 ± 8.21 | 63.50 ± 5.49 | <0.001 |
| Male, n (%) | 23965 (46.07) | 23690 (45.83) | 275 (83.59) | <0.001 |
| Ethnicity, n (%) | 0.124 | |||
|  White | 48524 (93.28) | 48205 (93.26) | 319 (96.96) | |
|  Mixed background | 343 (0.66) | 343 (0.66) | 0 (0.00) | |
|  South Asian | 959 (1.84) | 959 (1.86) | 0 (0.00) | |
|  Black | 1183 (2.27) | 1178 (2.28) | 5 (1.52) | |
|  Chinese | 145 (0.28) | 144 (0.28) | 1 (0.30) | |
|  Other | 608 (1.17) | 605 (1.17) | 3 (0.91) | |
|  Missing | 255 (0.49) | 254 (0.49) | 1 (0.30) | |
| Educational level, n (%) | <0.001 | |||
|  No relevant qualifications | 16605 (31.92) | 16546 (32.01) | 59 (17.93) | |
|  CSEs or equivalent | 5691 (10.94) | 5668 (10.97) | 23 (6.99) | |
|  O levels, GCSEs, or equivalent | 10735 (20.64) | 10666 (20.64) | 69 (20.97) | |
|  A level, AS levels, or equivalent | 2773 (5.33) | 2761 (5.34) | 12 (3.65) | |
|  College or university degree | 6174 (11.87) | 6111 (11.82) | 63 (19.15) | |
|  Others | 9155 (17.60) | 9055 (17.52) | 100 (30.40) | |
|  Missing | 884 (1.70) | 881 (1.70) | 3 (0.91) | |
| Townsend deprivation index, n (%) | 0.711 | |||
|  Q1 | 10288 (19.78) | 10224 (19.80) | 64 (19.45) | |
|  Q2 | 10233 (19.67) | 10169 (19.70) | 64 (19.45) | |
|  Q3 | 9841 (18.92) | 9774 (18.93) | 67 (20.36) | |
|  Q4 | 10568 (20.32) | 10510 (20.36) | 58 (17.63) | |
|  Q5 | 11024 (21.19) | 10948 (21.21) | 76 (23.10) | |
|  Missing | 63 (0.12) | |||
| Body mass index, n (%) | <0.001 | |||
|   kg/m2 | 268 (0.52) | 267 (0.52) | 1 (0.30) | |
|  18.5 to <25 kg/m2 | 16549 (31.81) | 16479 (32.04) | 70 (21.28) | |
|  25 to <30 kg/m2 | 22222 (42.72) | 22068 (42.91) | 154 (46.81) | |
|  ≥30 kg/m2 | 12724 (24.46) | 12620 (24.54) | 104 (31.61) | |
|  Missing | 254 (0.49) | |||
| Smoking status, n (%) | <0.001 | |||
|  Never | 28163 (54.14) | 28102 (54.37) | 61 (18.54) | |
|  Past | 18121 (34.84) | 17966 (34.76) | 155 (47.11) | |
|  Current | 5479 (10.53) | 5367 (10.38) | 112 (34.04) | |
| Missing | 254 (0.49) | 253 (0.49) | 1 (0.30) | |
| Alcohol drinking, n (%) | 0.997 | |||
|  Never | 2456 (4.72) | 2441 (4.72) | 15 (4.56) | |
|  Past | 2019 (3.88) | 2006 (3.88) | 13 (3.95) | |
|  Current | 47406 (91.14) | 47106 (91.14) | 300 (91.19) | |
|  Missing | 136 (0.26) | 135 (0.26) | 1 (0.30) | |
| Leisure time physical activity, n (%) | 0.037 | |||
|   MET/min/weeks | 18200 (34.99) | 18096 (35.01) | 104 (31.61) | |
|  500 to <1000 MET/min/weeks | 10689 (20.55) | 10630 (20.57) | 59 (17.93) | |
|  ≥1000 MET/min/weeks | 18424 (35.42) | 18301 (35.41) | 123 (37.39) | |
|  Missing | 4704 (9.04) | 4661 (9.02) | 43 (13.07) | |
| Healthy dietary, n (%) | 2356 (4.53) | 2342 (4.53) | 14 (4.26) | 0.884 |
|  Missing | 1971 (3.79) | 1960 (3.79) | 11 (3.34) | |
| Diabetes, n (%) | 2950 (5.67) | 2920 (5.65) | 30 (9.12) | 0.024 |
|  Missing | 227 (0.44) | 226 (0.44) | 1 (0.30) | |
| Hypertension, n (%) | 14592 (28.05) | 14429 (27.92) | 163 (49.54) | <0.001 |
|  Missing | 61 (0.12) | 61 (0.12) | 0 (0.00) | |
| Hyperlipidemia, n (%) | 6710 (12.90) | 6587 (12.74) | 123 (37.39) | <0.001 |
Demographic characteristics of participants from UK Biobank database.
Table 2
| Associations between baseline circulating level and risk of AAA. | ||||
|---|---|---|---|---|
| Variable | Crude HR (95% CI) | P-value | Adjusted HR (95% CI) * | P-value |
| CCL20, per 1-SD increase | 1.26 (1.15, 1.37) | <0.001 | 1.11 (1.00, 1.23) | 0.047 |
| CCL20, quartiles | ||||
| Q1 | 1.0 | 1.0 | ||
| Q2 | 1.30 (0.90, 1.89) | 0.167 | 1.05 (0.72, 1.53) | 0.803 |
| Q3 | 2.13 (1.51, 2.99 | <0.001 | 1.43 (1.01, 2.02) | 0.044 |
| Q4 | 2.47 (1.77, 3.45) | <0.001 | 1.44 (1.02, 2.03) | 0.040 |
High circulating CCL20 level predicted higher risk of AAA.
*Adjusted for age, sex, ethnicity, educational attainment, socioeconomic deprivation, body mass index, smoking status, alcohol drinking, healthy diet, leisure time physical activity, diabetes, hypertension, and hypercholesterolemia.
3.5 Macrophages recruited significant numbers of immune cells through the CCL20-CCR6 axis
As CCR6 is the sole receptor for CCL20 (33, 36, 37), we visualized its interaction relationship with CCL20 in the Cytokine-cytokine receptor interaction pathway (Supplementary Figure 4D). Single-cell datasets showed that CCR6 was mainly expressed in T cells and B cells (Figure 5A), a finding confirmed by IF co-localization in human AAA tissues (Figures 5B, C). Comparative analysis revealed significantly elevated CCR6 expression in T cells and B cells from AAA tissues (Figure 5D). Western blot and IF analyses further demonstrated higher CCR6 expression in human AAA tissues (Figures 5E–G; Supplementary Figures 5A, B). Consistently, CCR6 mRNA levels were upregulated in bulk RNA-seq datasets (Figure 5H). Thus, CCR6 expression was elevated in AAA tissues, primarily in T cells and B cells.
Figure 5
To explore potential chemokine-mediated communication involving macrophages during AAA, we performed CellChat analysis focusing on the CCL chemokine family. This analysis suggested enriched CCL-related communication patterns between macrophages and multiple immune cell types in AAA samples. In particular, inferred CCL20-CCR6-associated communication between macrophages and T cells, B cells, and NKT cells was predominantly observed in AAA tissues (Figure 5I). Consistent with the cellular composition revealed by single-cell datasets (Figures 1C, D), immunofluorescence analysis of human tissues showed no significant difference in macrophage abundance between groups, but demonstrated increased infiltration of adaptive immune cells, including T cells and B cells, in AAA tissues (Figure 5J). These observations, together with the inferred communication patterns, suggested a potential role for macrophage-derived CCL20-CCR6 signaling in immune cell recruitment within AAA lesions. To functionally test this hypothesis, we performed Transwell co-culture experiments using LPS-stimulated macrophages and T or B cells in the presence of a CCL20-neutralizing antibody (10 ng/ml). Flow cytometric analysis showed that blockade of the CCL20-CCR6 axis significantly reduced the migration of both T cells and B cells (Figures 5K, L). Collectively, these functional data support a role for macrophage-derived CCL20-CCR6 signaling in promoting immune cell migration, providing experimental validation for the communication patterns suggested by CellChat analysis.
3.6 Targeting the CCL20-CCR6 axis inhibited AAA progression
To validate the role of the CCL20-CCR6 axis in AAA development, we established an AAA model in ApoE–/– mice through Ang-II infusion (1,000 ng/kg/min). Interventions were administered via tail vein injections of a specific knockdown of AAV-shCCL20/AAV-shCCR6 (Figure 6A).
Figure 6
Specifically, RT-qPCR validated the knockdown efficiencies of CCL20 and CCR6 in aortic tissues. Expression levels of both CCL20 and CCR6 were significantly higher in the AAA group compared to controls (Figure 6B). Knockdown of CCL20 or CCR6 markedly reduced AAA incidence (Figure 6C). These findings were further corroborated by vascular Doppler ultrasound imaging and measurements of maximal external aortic diameter (Figures 6D–F). Morphological and histological analyses demonstrated that disrupting the CCL20-CCR6 axis attenuated inflammation, elastin degradation, and collagen deposition in the aortic wall (Figure 6G). Additionally, IF and IHC staining revealed elevated CCR6 expression alongside abundant infiltration of T cells and B cells in AAA tissues (Supplementary Figures 5C, D). In contrast, knockdown of CCL20 or CCR6 diminished the accumulation of these immune cells (Figure 6H). By using F4/80+CD86+iNOS+ as representative M1-like markers and F4/80+CD206+Arg1+ as representative M2-like markers in multiplex immunofluorescence, we further validated the macrophage polarization status. The experimental results indicate that blockade the CCL20-CCR6 axis weakened the pro-inflammatory M1 polarization tendency and enhanced the anti-inflammatory M2 polarization tendency (Supplementary Figure 6). Collectively, these results indicate that targeting the CCL20-CCR6 axis reduces T cell and B cell infiltration and suppresses AAA progression.
4 Discussion
This study employed integrated single-cell and bulk RNA sequencing, alongside experimental and external data validations, to elucidate the cellular and molecular underpinnings of AAA pathogenesis. Our analyses revealed profound immune cell infiltration (particularly T cells and B cells) and structural cell depletion (fibroblasts, endothelial cells, and SMCs) in AAA tissues, driven by imbalanced macrophage polarization favoring pro-inflammatory M1-like macrophages. This imbalance promoted CCL20 secretion, which recruits CCR6-expressing immune cells (CCR6+ T cells and CCR6+ B cells) into the aneurysmal tissue. ELISA and IF analyses confirmed significantly elevated CCL20 levels in serum and tissue samples from AAA patients. Using a knockdown model of the CCL20-CCR6 axis in AAA and an in vitro neutralization model of CCL20-mediated macrophage chemotaxis, we evaluated the axis’s impact on AAA. Our findings highlight the CCL20-CCR6 axis as a key regulator of AAA pathogenesis (Figure 7) and a potential therapeutic target.
Figure 7
Macrophage infiltration and polarization evolve throughout aneurysm development (8). We note that M1/M2-like macrophage signatures represent simplified polarization axes and do not capture the full spectrum of macrophage heterogeneity; therefore, these results should be interpreted as functional tendencies rather than discrete macrophage subtypes. Additionally, cytokine-cytokine receptor interaction pathways were highly activated in AAA macrophages. Our results showed no significant difference in macrophage proportions between the AAA and normal groups with the imbalance between M1-like and M2-like macrophage polarization. Macrophage polarization is a critical driver of AAA (56–59). Pro-inflammatory M1 macrophages accelerate AAA by exacerbating inflammation and secreting cytokines (22, 60, 61). In our study, M1-like macrophage polarization and altered gene expression profiles were evident in AAA macrophages, with an imbalance favoring M1-like over M2-like. IL-1α, CXCL10, and CCL20 emerged as the top three secreted chemokines, with IL-1α and CXCL10 previously implicated in AAA pathogenesis (62, 63). This study focuses on the third key chemokine, CCL20, and its exclusive receptor, CCR6, to delineate their specific roles in shaping the AAA immune microenvironment and driving AAA progression (64). The CCL20-CCR6 axis regulates immune responses in cardiovascular diseases (37), but its role in AAA remains underexplored. We observed that M1-like macrophage polarization significantly increased CCL20 expression in AAA serum and tissues. Consistent with the previous study (55), CCL20 serves as a potential AAA biomarker in large cohorts based on our and UK Biobank data. Due to challenges in obtaining normal aortic tissue, the sample size for the normal group (n=5) was relatively small. However, our study has demonstrated the pivotal role of the CCL20-CCR6 axis in AAA. Future research with larger sample sizes will be essential.
Immune cell infiltration has long been recognized as a fundamental mechanism in the chronic inflammatory progression of AAA, with chemokines playing a pivotal role (20, 65, 66). Consistent with previous findings (67), our single-cell analysis revealed a profound cellular imbalance in AAA tissues, characterized by extensive immune cell infiltration (T cells and B cells) and loss of structural cells (fibroblasts, endothelial cells, and SMCs). Ro/e analysis further demonstrated that immune cells (T cells and B cells) exhibited a significant tissue preference towards AAA tissues, suggesting a strong association with aneurysm progression risk. Given the limited donor number, Ro/e analysis was used as a descriptive tool to summarize cell-type distribution trends, and future studies with larger cohorts will be required for robust donor-level inference. CellChat analysis indicated macrophages emerged as particularly prominent in communication with T cells, B cells, and NKT cells in AAA group. CellChat-based communication analyses are inferential and hypothesis-generating, and future donor-aware modeling and functional validation will be required to further define the biological relevance of these signaling pathways.
We propose that the active CCL20-CCR6 axis provide a mechanistic framework to explain this specific recruitment of CCR6-expressing immune cells (CCR6+ T cells and CCR6+ B cells) and the ensuing inflammatory cascade. T cells represent the dominant immune cell population in AAA (25), where they can promote AAA formation and stimulate macrophages to produce pro-inflammatory mediators in AAA models like Interleukin-17 (IL-17) and TNF-α (15, 68, 69). IL-17 can stimulate SMCs and fibroblasts to secrete matrix metalloproteinases and pro-inflammatory cytokines including CCL20, thereby establishing a positive feedback loop that sustains continuous lymphocyte recruitment (70, 71). Furthermore, cytokines from other T cell subsets, such as Interferon-gamma (IFN-γ) from Th1 cells, can contribute to orchestrate extracellular matrix remodeling (68). Concurrently, infiltrating B cells influence AAA progression by secreting immunoglobulins (e.g., Immunoglobulin A&Immunoglobulin G) and cytokines like IL-6 and TNF-α, which degrade the aortic wall and exacerbate inflammatory responses (16). Depleting B cells protects mice from experimental AAA and fosters an immunosuppressive aortic environment (30). The CCL20-CCR6 axis links macrophage activation to the targeted recruitment of CCR6+ T cells and CCR6+ B cells. The secretory products of these effector cells act back on vascular wall cells and immune cells, aggravating the inflammatory response and accelerating aneurysm progression.
Inhibiting chemokine axes has proven effective in AAA animal models, such as CCL5-CCR5 or CCL2-CCR2 pathways (72–74). The CCL20-CCR6 axis is vital in regulating immune responses during chronic inflammation in AAA, underscoring the need to develop therapeutic strategies targeting the axis. Overexpressed CCL20 promotes aortic elastin degradation, inhibits M2 polarization, and accelerates AAA (34), suggesting it exacerbates inflammation and drives progression. In atherosclerosis, the deletion of CCR6 effectively ameliorates inflammatory progression and plaque size (41, 75). However, the mechanisms and efficacy of targeting CCL20-CCR6 in AAA are unclear. Our study provides initial evidence that blockade of this axis reduces aortic diameter, aneurysm incidence, and immune cells infiltration in AngII-induced ApoE–/– male mice AAA model under a high-fat diet, potential gender bias in the effects should be considered. Consistent with prior studies, our AAA model successfully recapitulates the key pathological features of human AAA, including chronic inflammation and macrophage-dominated immune infiltration (11, 76). Although there are potential differences in the specific immune cell subset proportions and the disease timeline from AAA in human, the model has been used to explore the role of CCL20-CCR6 axis in AAA-related vascular lesions and immune features (34).
This study integrates bioinformatics analysis with experimental validation to explore the cellular and molecular mechanisms underlying AAA pathogenesis. Our analysis reveals a key role of CCL20 secretion, driven by an imbalance in M1-like macrophages polarization, which recruits CCR6+ immune cells (such as CCR6+ T cells and CCR6+ B cells) to promote AAA development. Our experimental framework already integrates two levels of evidence: 1) Genetic Evidence in vivo (AAV-shCCL20 knockdown) demonstrating the necessity of CCL20 in disease progression within the complex tissue microenvironment; 2) Pharmacological Evidence in vitro (CCL20-neutralizing antibody) confirming the functional consequence of blockade the CCL20-CCR6 axis. While our genetic intervention lays a crucial mechanistic groundwork, future pharmacological validation using CCL20-neutralizing antibodies or receptor antagonists in vivo will be an essential next step toward clinical translation.
5 Conclusion
Macrophage-derived CCL20 recruited CCT6+ lymphocytes and promoted AAA progression. Inhibition of the CCL20-CCR6 axis reduced the recruitment of immune cells and relieved AAA progression. CCL20 may serve as a novel diagnostic biomarker and therapeutic target for AAA.
Statements
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material. Further inquiries can be directed to the corresponding author/s.
Ethics statement
The studies involving humans were approved by the Ethics Committee of Qilu Hospital of Shandong University (Approval No.: KYLL-202503-09-046-1). The studies were conducted in accordance with the local legislation and institutional requirements. The human samples used in this study were acquired from Written informed consent was obtained from all participants or the organ donors’ families. Human AAA tissues were collected from six patients (4 males, 2 females; age range: 58-71 years, median: 67.5) undergoing open surgical repair, and normal aortic tissues from six organ donors (5 males, 1 female; age range: 16-74 years, median: 53.5) deceased from cerebral hemorrhage. Written informed consent for participation was not required from the participants or the participants’ legal guardians/next of kin in accordance with the national legislation and institutional requirements. The animal study was approved by the Experimental Animal Ethics Committee of Qilu Hospital of Shandong University (Approval No.: DWLL-2024-214). The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
QR: Conceptualization, Investigation, Resources, Writing – original draft, Writing – review & editing. TS: Data curation, Formal analysis, Methodology, Writing – original draft, Writing – review & editing. SS: Funding acquisition, Investigation, Resources, Writing – original draft, Writing – review & editing. YC: Investigation, Resources, Writing – original draft. LW: Investigation, Resources, Writing – original draft. YZ: Investigation, Resources, Writing – original draft. FW: Investigation, Resources, Writing – original draft. PS: Investigation, Resources, Writing – original draft. KX: Investigation, Resources, Writing – original draft. HB: Data curation, Formal analysis, Methodology, Writing – original draft. DG: Formal analysis, Methodology, Writing – original draft. QH: Data curation, Formal analysis, Methodology, Writing – original draft. MZ: Data curation, Formal analysis, Writing – original draft. JY: Project administration, Supervision, Validation, Writing – original draft. JJ: Project administration, Supervision, Validation, Writing – original draft. WZ: Conceptualization, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing. XD: Conceptualization, Funding acquisition, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing.
Funding
The author(s) declared that financial support was received for this work and/or its publication. This work was supported by the projects funded by the Natural Science Foundation of Shandong Province (No. ZR2021MH316, ZR2024ZD23, and ZR2024QH226), the National Natural Science Foundation of China (No. 82401119), and the Postdoctoral Innovation Program of Shandong Province (No. 202003007).
Acknowledgments
The authors thank Prof. Qiang Fen, Prof. Xiaopeng Qi, Dr. Lei Zheng, and Dr. Yanfeng Li from Shandong University for their valuable help and suggestions. We are grateful to Prof. Hui Zhang, Prof. Zeyang Liu, and Prof. Zhaogang Dong from Qilu Hospital of Shandong University for human sample collection. We also thank Dr. Tao Tang from the Department of Pathology, 971 Hospital of the Navy of the Chinese People′ s Liberation Army, for his invaluable assistance. We thank Medjaden Inc. for scientific editing of this manuscript.
Conflict of interest
The authors declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fimmu.2026.1780720/full#supplementary-material
References
1
LiuYWangHYuMCaiLZhaoYChengYet al. Hypertriglyceridemia as a key contributor to abdominal aortic aneurysm development and rupture: insights from genetic and experimental models. Circulation. (2025) 152:862–81. doi: 10.1161/circulationaha.125.074737
2
NordonIMHinchliffeRJLoftusIMThompsonMM. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nat Rev Cardiol. (2011) 8:92–102. doi: 10.1038/nrcardio.2010.180
3
KontopodisNGalanakisNAntoniouSATsetisDIoannouCVVeithFJet al. Meta-analysis and meta-regression analysis of outcomes of endovascular and open repair for ruptured abdominal aortic aneurysm. Eur J Vasc Endovasc Surg. (2020) 59:399–410. doi: 10.1016/j.ejvs.2019.12.023
4
SakalihasanNMichelJBKatsargyrisAKuivaniemiHDefraigneJONchimiAet al. Abdominal aortic aneurysms. Nat Rev Dis Primers. (2018) 4:34. doi:Â 10.1038/s41572-018-0030-7
5
FilibertoACSpinosaMDElderCTSuGLeroyVLaddZet al. Endothelial pannexin-1 channels modulate macrophage and smooth muscle cell activation in abdominal aortic aneurysm formation. Nat Commun. (2022) 13:1521. doi:Â 10.1038/s41467-022-29233-4
6
AnagnostakosJLalBK. Abdominal aortic aneurysms. Prog Cardiovasc Dis. (2021) 65:34–43. doi: 10.1016/j.pcad.2021.03.009
7
WangSKMurphyMP. Immune modulation as a treatment for abdominal aortic aneurysms. Circ Res. (2018) 122:925–7. doi: 10.1161/circresaha.118.312870
8
RaffortJLareyreFClémentMHassen-KhodjaRChinettiGMallatZ. Monocytes and macrophages in abdominal aortic aneurysm. Nat Rev Cardiol. (2017) 14:457–71. doi: 10.1038/nrcardio.2017.52
9
DunkelbergerJRSongWC. Complement and its role in innate and adaptive immune responses. Cell Res. (2010) 20:34–50. doi: 10.1038/cr.2009.139
10
AdamMKooremanNGJaggerAWagenhäuserMUMehrkensDWangYet al. Systemic upregulation of il-10 (Interleukin-10) using a nonimmunogenic vector reduces growth and rate of dissecting abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. (2018) 38:1796–805. doi: 10.1161/atvbaha.117.310672
11
SawadaHLuHSCassisLADaughertyA. Twenty years of studying angii (Angiotensin ii)-induced abdominal aortic pathologies in mice: continuing questions and challenges to provide insight into the human disease. Arterioscler Thromb Vasc Biol. (2022) 42:277–88. doi: 10.1161/atvbaha.121.317058
12
XiaoJAngsanaJWenJSmithSVParkPWFordMLet al. Syndecan-1 displays a protective role in aortic aneurysm formation by modulating T cell-mediated responses. Arterioscler Thromb Vasc Biol. (2012) 32:386–96. doi: 10.1161/atvbaha.111.242198
13
DaleMARuhlmanMKBaxterBT. Inflammatory cell phenotypes in AAAS: their role and potential as targets for therapy. Arterioscler Thromb Vasc Biol. (2015) 35:1746–55. doi: 10.1161/atvbaha.115.305269
14
GaoJCaoHHuGWuYXuYCuiHet al. The mechanism and therapy of aortic aneurysms. Signal Transduct Target Ther. (2023) 8:55. doi:Â 10.1038/s41392-023-01325-7
15
SaganAMikolajczykTPMrowieckiWMacRitchieNDalyKMeldrumAet al. T cells are dominant population in human abdominal aortic aneurysms and their infiltration in the perivascular tissue correlates with disease severity. Front Immunol. (2019) 10:1979. doi:Â 10.3389/fimmu.2019.01979
16
ZhangLWangY. B lymphocytes in abdominal aortic aneurysms. Atherosclerosis. (2015) 242:311–7. doi: 10.1016/j.atherosclerosis.2015.07.036
17
SpinosaMDMontgomeryWGLempickiMSrikakulapuPJohnsrudeMJMcNamaraCAet al. B cell-activating factor antagonism attenuates the growth of experimental abdominal aortic aneurysm. Am J Pathol. (2021) 191:2231–44. doi: 10.1016/j.ajpath.2021.08.012
18
YuHJiaoXLvQLiLDuYHuCet al. Atf4 contributes to abdominal aortic aneurysm formation via modulating M1 macrophage polarization and inflammation. Aging Dis. (2024) 16:1691–708. doi: 10.14336/ad.2024.0116
19
SongHYangYSunYWeiGZhengHChenYet al. Circular rna cdyl promotes abdominal aortic aneurysm formation by inducing M1 macrophage polarization and M1-type inflammation. Mol Ther. (2022) 30:915–31. doi: 10.1016/j.ymthe.2021.09.017
20
OrtegaRColladoASellesFGonzalez-NavarroHSanzMJRealJTet al. Sglt-2 (Sodium-glucose cotransporter 2) inhibition reduces Ang ii (Angiotensin ii)-induced dissecting abdominal aortic aneurysm in ApoE (Apolipoprotein E) knockout mice. Arterioscler Thromb Vasc Biol. (2019) 39:1614–28. doi: 10.1161/atvbaha.119.312659
21
HouNZhouHLiJXiongXDengHXiongS. Macrophage polarization and metabolic reprogramming in abdominal aortic aneurysm. Immun Inflammation Dis. (2024) 12:e1268. doi:Â 10.1002/iid3.1268
22
DaleMAXiongWCarsonJSSuhMKKarpisekADMeisingerTMet al. Elastin-derived peptides promote abdominal aortic aneurysm formation by modulating M1/M2 macrophage polarization. J Immunol. (2016) 196:4536–43. doi: 10.4049/jimmunol.1502454
23
YuanZShuLFuJYangPWangYSunJet al. Single-cell rna sequencing deconstructs the distribution of immune cells within abdominal aortic aneurysms in mice. Arterioscler Thromb Vasc Biol. (2024) 44:1986–2003. doi: 10.1161/atvbaha.124.321129
24
ShimizuKShichiriMLibbyPLeeRTMitchellRN. Th2-predominant inflammation and blockade of ifn-gamma signaling induce aneurysms in allografted aortas. J Clin Invest. (2004) 114:300–8. doi: 10.1172/jci19855
25
LindholtJSShiGP. Chronic inflammation, immune response, and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. (2006) 31:453–63. doi: 10.1016/j.ejvs.2005.10.030
26
OcanaEBohórquezJCPérez-RequenaJBrievaJARodrÃguezC. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis. (2003) 170:39–48. doi: 10.1016/s0021-9150(03)00282-x
27
ChangTWGraconASMurphyMPWilkesDS. Exploring autoimmunity in the pathogenesis of abdominal aortic aneurysms. Am J Physiol Heart Circ Physiol. (2015) 309:H719–27. doi: 10.1152/ajpheart.00273.2015
28
CaligiuriGRossignolPJuliaPGroyerEMouradianDUrbainDet al. Reduced immunoregulatory cd31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. (2006) 26:618–23. doi: 10.1161/01.ATV.0000200380.73876.d9
29
MeherAKJohnstonWFLuGPopeNHBhamidipatiCMHarmonDBet al. B2 cells suppress experimental abdominal aortic aneurysms. Am J Pathol. (2014) 184:3130–41. doi: 10.1016/j.ajpath.2014.07.006
30
SchaheenBDownsEASerbuleaVAlmenaraCCSpinosaMSuGet al. B-cell depletion promotes aortic infiltration of immunosuppressive cells and is protective of experimental aortic aneurysm. Arterioscler Thromb Vasc Biol. (2016) 36:2191–202. doi: 10.1161/atvbaha.116.307559
31
FurushoAAokiHOhno-UrabeSNishiharaMHirakataSNishidaNet al. Involvement of B cells, immunoglobulins, and syk in the pathogenesis of abdominal aortic aneurysm. J Am Heart Assoc. (2018) 7:e007750. doi:Â 10.1161/jaha.117.007750
32
Márquez-SánchezACKoltsovaEK. Immune and inflammatory mechanisms of abdominal aortic aneurysm. Front Immunol. (2022) 13:989933. doi: 10.3389/fimmu.2022.989933
33
SchutyserEStruyfSVan DammeJ. The cc chemokine ccl20 and its receptor ccr6. Cytokine Growth Factor Rev. (2003) 14:409–26. doi: 10.1016/s1359-6101(03)00049-2
34
LiYLiRLiYLiGZhaoYMouHet al. Transcription factor tcf3 promotes macrophage-mediated inflammation and mmp secretion in abdominal aortic aneurysm by regulating mir-143-5p/ccl20. J Cardiovasc Pharmacol. (2023) 82:458–69. doi: 10.1097/fjc.0000000000001484
35
CalvayracORodrÃguez-CalvoRAlonsoJOrbeJMartÃn-VenturaJLGuadallAet al. Ccl20 is increased in hypercholesterolemic subjects and is upregulated by ldl in vascular smooth muscle cells: role of nf-Kb. Arterioscler Thromb Vasc Biol. (2011) 31:2733–41. doi: 10.1161/atvbaha.111.235721
36
HouLYukiK. Ccr6 and cxcr6 identify the th17 cells with cytotoxicity in experimental autoimmune encephalomyelitis. Front Immunol. (2022) 13:819224. doi:Â 10.3389/fimmu.2022.819224
37
WanWMurphyPM. Regulation of atherogenesis by chemokine receptor ccr6. Trends Cardiovasc Med. (2011) 21:140–4. doi: 10.1016/j.tcm.2012.04.003
38
Armas-GonzálezEDomÃnguez-LuisMJDÃaz-MartÃnAArce-FrancoMCastro-HernándezJDanelonGet al. Role of cxcl13 and ccl20 in the recruitment of B cells to inflammatory foci in chronic arthritis. Arthritis Res Ther. (2018) 20:114. doi: 10.1186/s13075-018-1611-2
39
BruneauSNakayamaHWodaCBFlynnEABriscoeDM. Deptor regulates vascular endothelial cell activation and proinflammatory and angiogenic responses. Blood. (2013) 122:1833–42. doi: 10.1182/blood-2013-03-488486
40
MantheyHDCochainCBarnsteinerSKarshovskaEPelisekJKochMet al. Ccr6 selectively promotes monocyte mediated inflammation and atherogenesis in mice. Thromb Haemost. (2013) 110:1267–77. doi: 10.1160/th13-01-0017
41
WanWLimJKLionakisMSRivollierAMcDermottDHKelsallBLet al. Genetic deletion of chemokine receptor ccr6 decreases atherogenesis in apoe-deficient mice. Circ Res. (2011) 109:374–81. doi: 10.1161/circresaha.111.242578
42
SénémaudJCaligiuriGEtienneHDelboscSMichelJBCoscasR. Translational relevance and recent advances of animal models of abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. (2017) 37:401–10. doi: 10.1161/atvbaha.116.308534
43
HaoYHaoSAndersen-NissenEMauckWM3rdZhengSButlerAet al. Integrated analysis of multimodal single-cell data. Cell. (2021) 184:3573–87.e29. doi: 10.1016/j.cell.2021.04.048
44
McGinnisCSMurrowLMGartnerZJ. Doubletfinder: doublet detection in single-cell rna sequencing data using artificial nearest neighbors. Cell Syst. (2019) 8:329–37.e4. doi: 10.1016/j.cels.2019.03.003
45
WangWCenYLuZXuYSunTXiaoYet al. ScCDC: a computational method for gene-specific contamination detection and correction in single-cell and single-nucleus RNA-seq data. Genome Biol. (2024) 25:136. doi:Â 10.1186/s13059-024-03284-w
46
ZhangLYuXZhengLZhangYLiYFangQet al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature. (2018) 564:268–72. doi: 10.1038/s41586-018-0694-x
47
JinSPlikusMVNieQ. Cellchat for systematic analysis of cell-cell communication from single-cell transcriptomics. Nat Protoc. (2025) 20:180–219. doi: 10.1038/s41596-024-01045-4
48
RitchieMEPhipsonBWuDHuYLawCWShiWet al. Limma powers differential expression analyses for rna-sequencing and microarray studies. Nucleic Acids Res. (2015) 43:e47. doi:Â 10.1093/nar/gkv007
49
RobinsonMDMcCarthyDJSmythGK. Edger: A bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. (2010) 26:139–40. doi: 10.1093/bioinformatics/btp616
50
YuGWangLGHanYHeQY. Clusterprofiler: an R package for comparing biological themes among gene clusters. Omics. (2012) 16:284–7. doi: 10.1089/omi.2011.0118
51
NewmanAMLiuCLGreenMRGentlesAJFengWXuYet al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. (2015) 12:453–7. doi: 10.1038/nmeth.3337
52
SunDGuanXMoranAEWuLYQianDZSchedinPet al. Identifying phenotype-associated subpopulations by integrating bulk and single-cell sequencing data. Nat Biotechnol. (2022) 40:527–38. doi: 10.1038/s41587-021-01091-3
53
ZhaoGLuHChangZZhaoYZhuTChangLet al. Single-cell rna sequencing reveals the cellular heterogeneity of aneurysmal infrarenal abdominal aorta. Cardiovasc Res. (2021) 117:1402–16. doi: 10.1093/cvr/cvaa214
54
WangZYChengJWangYYuanHTBiSJWangSXet al. Macrophage ilf3 promotes abdominal aortic aneurysm by inducing inflammatory imbalance in male mice. Nat Commun. (2024) 15:7249. doi:Â 10.1038/s41467-024-51030-4
55
SotoBGallastegi-MozosTRodrÃguezCMartÃnez-GonzálezJEscuderoJRVilaLet al. Circulating ccl20 as a new biomarker of abdominal aortic aneurysm. Sci Rep. (2017) 7:17331. doi: 10.1038/s41598-017-17594-6
56
CaiDSunCMurashitaTQueXChenSY. Adar1 non-editing function in macrophage activation and abdominal aortic aneurysm. Circ Res. (2023) 132:e78–93. doi: 10.1161/circresaha.122.321722
57
MaYDingXJLuSYHuangXFHuYYLiuHet al. M2 Macrophage-Derived Extracellular Vesicles Protect against Abdominal Aortic Aneurysm by Modulating Macrophage Polarization through Mir221-5p. Cell Mol Biol Lett. (2025) 30:96. doi:Â 10.1186/s11658-025-00768-w
58
WuWTangWLiangWLiQQiXGaoRet al. Gdf15 suppresses abdominal aortic aneurysm by upregulating areg expression to adjust macrophage polarization. Int Immunopharmacol. (2025) 159:114899. doi:Â 10.1016/j.intimp.2025.114899
59
ShenLYuJChenWBiYYangZLuCet al. Ppp1r3b suppresses atherosclerosis by promoting the M2 polarization of macrophages through glycogen metabolic reprogramming. Adv Sci (Weinh). (2025) 12, e06345. doi:Â 10.1002/advs.202506345
60
WangJDaXChenYYuanAPuJ. Glutamine Protects against Mouse Abdominal Aortic Aneurysm through Modulating Vsmc Apoptosis and M1 Macrophage Activation. Int J Med Sci. (2024) 21:1414–27. doi: 10.7150/ijms.96395
61
WuZZhangPYueJWangQZhuangPJehanSet al. Tea polyphenol nanoparticles enable targeted sirna delivery and multi-bioactive therapy for abdominal aortic aneurysms. J Nanobiotechnol. (2024) 22:471. doi:Â 10.1186/s12951-024-02756-2
62
KingVLLinAYKristoFAndersonTJAhluwaliaNHardyGJet al. Interferon-gamma and the interferon-inducible chemokine cxcl10 protect against aneurysm formation and rupture. Circulation. (2009) 119:426–35. doi: 10.1161/circulationaha.108.785949
63
MiddletonRKLloydGMBownMJCooperNJLondonNJSayersRD. The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study. J Vasc Surg. (2007) 45:574–80. doi: 10.1016/j.jvs.2006.11.020
64
MeiteiHTJadhavNLalG. Ccr6-ccl20 axis as a therapeutic target for autoimmune diseases. Autoimmun Rev. (2021) 20:102846. doi:Â 10.1016/j.autrev.2021.102846
65
RizasKDIppaguntaNTilsonMD3rd. Immune cells and molecular mediators in the pathogenesis of the abdominal aortic aneurysm. Cardiol Rev. (2009) 17:201–10. doi: 10.1097/CRD.0b013e3181b04698
66
ZhaoGChoCSLiuHHwangYSiYKimMet al. Single-cell spatial transcriptomics unravels the cellular landscape of abdominal aortic aneurysm. JCI Insight. (2025) 10:e190534. doi:Â 10.1172/jci.insight.190534
67
DavisFMTsoiLCMaFWasikowskiRMooreBBKunkelSLet al. Single-cell transcriptomics reveals dynamic role of smooth muscle cells and enrichment of immune cell subsets in human abdominal aortic aneurysms. Ann Surg. (2022) 276:511–21. doi: 10.1097/sla.0000000000005551
68
GalleCSchandenéLStordeurPPeignoisYFerreiraJWautrechtJ-Cet al. Predominance of type 1 cd4+T cells in human abdominal aortic aneurysm. Clin Exp Immunol. (2005) 142:519–27. doi: 10.1111/j.1365-2249.2005.02938.x
69
XiongWZhaoYPrallAGreinerTCBaxterBT. Key roles of cd4+ T cells and ifn-gamma in the development of abdominal aortic aneurysms in a murine model. J Immunol. (2004) 172:2607–12. doi: 10.4049/jimmunol.172.4.2607
70
WeiZWangYZhangKLiaoYYePWuJet al. Inhibiting the th17/il-17a-related inflammatory responses with digoxin confers protection against experimental abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol. (2014) 34:2429–38. doi: 10.1161/atvbaha.114.304435
71
KogaTOtomoKMizuiMYoshidaNUmedaMIchinoseKet al. Calcium/calmodulin-dependent kinase iv facilitates the recruitment of interleukin-17-producing cells to target organs through the ccr6/ccl20 axis in th17 cell-driven inflammatory diseases. Arthritis Rheumatol. (2016) 68:1981–8. doi: 10.1002/art.39665
72
IidaYXuBXuanHGloverKJTanakaHHuXet al. Peptide inhibitor of cxcl4-ccl5 heterodimer formation, mkey, inhibits experimental aortic aneurysm initiation and progression. Arterioscler Thromb Vasc Biol. (2013) 33:718–26. doi: 10.1161/atvbaha.112.300329
73
de WaardVBotIde JagerSCTalibSEgashiraKde VriesMRet al. Systemic mcp1/ccr2 blockade and leukocyte specific mcp1/ccr2 inhibition affect aortic aneurysm formation differently. Atherosclerosis. (2010) 211:84–9. doi: 10.1016/j.atherosclerosis.2010.01.042
74
MoranCSJoseRJMoxonJVRoombergANormanPERushCet al. Everolimus limits aortic aneurysm in the apolipoprotein E-deficient mouse by downregulating C-C chemokine receptor 2 positive monocytes. Arterioscler Thromb Vasc Biol. (2013) 33:814–21. doi: 10.1161/atvbaha.112.301006
75
QunLWendaXWeihongSJianyangMWeiCFangzhouLet al. Mirna-27b modulates endothelial cell angiogenesis by directly targeting naa15 in atherogenesis. Atherosclerosis. (2016) 254:184–92. doi: 10.1016/j.atherosclerosis.2016.10.007
76
Lysgaard PoulsenJStubbeJLindholtJS. Animal models used to explore abdominal aortic aneurysms: A systematic review. Eur J Vasc Endovasc Surg. (2016) 52:487–99. doi: 10.1016/j.ejvs.2016.07.004
Summary
Keywords
abdominal aortic aneurysm, C-C motif chemokine ligand 20, C-C motif chemokine receptor 6, CCL20-CCR6 axis, vascular disease
Citation
Ren Q, Sun T, Shen S, Cao Y, Wei L, Zhao Y, Wan F, Sui P, Xiao K, Bai H, Guo D, He Q, Zhi M, Yang J, Jiang J, Zhang W and Ding X (2026) Macrophage-derived CCL20 promotes abdominal aortic aneurysm progression via lymphocytes CCR6. Front. Immunol. 17:1780720. doi: 10.3389/fimmu.2026.1780720
Received
04 January 2026
Revised
10 February 2026
Accepted
16 February 2026
Published
02 March 2026
Volume
17 - 2026
Edited by
Zhirui Zeng, Guizhou Medical University, China
Reviewed by
YuFeng Zhang, Nanjing University of Chinese Medicine, China
Hadjer Namous, Independent Researcher, Madison, WI, United States
Updates
Copyright
© 2026 Ren, Sun, Shen, Cao, Wei, Zhao, Wan, Sui, Xiao, Bai, Guo, He, Zhi, Yang, Jiang, Zhang and Ding.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wencheng Zhang, zhangwencheng@sdu.edu.cn; Xiangjiu Ding, xiangjiu-ding@sdu.edu.cn
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.